Antineoplastic and immunomodulating agents.
Conclusion of a non-exclusive discount contract in accordance with Section 130a Para. 8 sgb v on medicinal products with the active ingredient filgrastim.
Conclusion of a non-exclusive discount contract in accordance with Section 130a Para. 8 sgb v on medicinal products with the active ingredient filgrastim.
Classified in :
#Medicinal Product
#Antineoplastic Agent
#Immunomodulator
Partner Opportunity
Key Location
Germany
Key Value
Worth :
Ref Doc
| EMD | : | Refer Document |
| Doc Fees | : | Refer Document |
Due on
27-Sep-2022
-1209 Days Left
| Days to go | : | -1209 Days |
| Opening on | : | Refer Document |
| Published on | : | 20-Oct-2020 |
